TCM obtains loan license from Central Drugs Standard Control Organisation

21 Sep 2020 Evaluate

TCM has now obtained the loan license to manufacture for sale or for distribution of Class C or Class D medical device from the Central Drugs Standard Control Organisation (COSCO) for manufacturing SARS-COV-2 RT PCR Kits with the use of Technology licensed by IIT-Delhi on a non-exclusive basis. FITI will provide the technical support for implementation of the License.

TCM is engaged in the manufacture of Potassium Chlorate - a vital raw material for the match Industry.

TCM Share Price

69.52 -2.78 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×